EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudie

Thrombolysis-to-Puncture Time Determines the Differential Effect of Tenecteplase Versus Alteplase in Large Vessel Occlusion

Lu Wang iD, Fuxia Yang iD, Xiao Wu, Lulan Li, Xueqiao Jiao iD, Fangfang Zhang, Fengyuan Che, Hongxing Han, Weidong Liu, Peifu Wang, Jia Liu, Xunming Ji und 1 weitere

Stroke · 2026-06 · 57 (6) · 1615-1623

DOI: 10.1161/strokeaha.125.054791 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Stroke, 2026-06. Verfasst von Lu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital (L.W., F.Y., X.W., L.L., X. Jiao, F.Z., X. Ji, X.G.), Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Tenecteplase, Tissue Plasminogen Activator, Fibrinolytic Agents, Thrombolytic Therapy. Die Arbeit nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Tenecteplase improves reperfusion and functional outcomes compared with alteplase in patients with large vessel occlusion. We assessed whether this superiority varies with thrombolysis-to-puncture time (TTP). METHODS: This retrospective analysis of a prospective multicenter cohort included patients with large vessel occlusion who received bridging therapy with either tenecteplase or alteplase between January 2022 and September 2025. Patients were stratified by TTP (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenecteplaseTissue Plasminogen ActivatorFibrinolytic AgentsThrombolytic TherapyIschemic StrokeStrokeHumansMaleRetrospective StudiesFemaleAgedMiddle AgedTreatment OutcomePuncturesTime FactorsTime-to-TreatmentProspective Studies

Stichwörter der Autor:innen

functional statushalf-lifeischemic stroketenecteplasetissue plasminogen activator

Substanzen

TenecteplaseTissue Plasminogen ActivatorFibrinolytic Agents

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital (L.W., F.Y., X.W., L.L., X. Jiao, F.Z., X. Ji, X.G.), Capital Medical University, Beijing, China.
  • Department of Neurology, Linyi People's Hospital, China (F.C., H.H.).
  • Department of Neurosurgery, Liaocheng People's Hospital, China (W.L.).
  • Department of Neurology, Aerospace Center Hospital, Beijing, China (P.W.).
  • Hypoxia Conditioning Translational Laboratory of Clinical Medicine (J.L., X.G.), Capital Medical University, Beijing, China.

ORCID-Profile: Lu Wang, Fuxia Yang, Xueqiao Jiao, Xiuhai Guo

Zitieren

APA

Wang, L., Yang, F., Wu, X., Li, L., Jiao, X., Zhang, F., Che, F., Han, H., Liu, W., Wang, P., Liu, J., Ji, X., & Guo, X. (2026). Thrombolysis-to-Puncture Time Determines the Differential Effect of Tenecteplase Versus Alteplase in Large Vessel Occlusion. Stroke, 57(6), 1615-1623. https://doi.org/10.1161/strokeaha.125.054791

Vancouver

Wang L, Yang F, Wu X, Li L, Jiao X, Zhang F, et al. Thrombolysis-to-Puncture Time Determines the Differential Effect of Tenecteplase Versus Alteplase in Large Vessel Occlusion. Stroke. 2026;57(6):1615-1623. doi:10.1161/strokeaha.125.054791

BibTeX
@article{Wang2026,
  author = {Wang, Lu and Yang, Fuxia and Wu, Xiao and Li, Lulan and Jiao, Xueqiao and Zhang, Fangfang and Che, Fengyuan and Han, Hongxing and Liu, Weidong and Wang, Peifu and Liu, Jia and Ji, Xunming and Guo, Xiuhai},
  title = {Thrombolysis-to-Puncture Time Determines the Differential Effect of Tenecteplase Versus Alteplase in Large Vessel Occlusion},
  journal = {Stroke},
  year = {2026},
  volume = {57},
  number = {6},
  pages = {1615--1623},
  doi = {10.1161/strokeaha.125.054791}
}
Kostenlos starten →